Metabolic Syndrome as a Risk Factor for Cardiovascular Disease, Mortality, and Progression of Diabetic Nephropathy in Type 1 Diabetes

OBJECTIVE: To assess the predictive value of the metabolic syndrome in patients with type 1 diabetes. RESEARCH DESIGN AND METHODS: Patients were from the prospective Finnish Diabetic Nephropathy (FinnDiane) Study (n = 3,783): mean age 37 ± 12 years and diabetes duration 23 ± 12 years. Metabolic synd...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorn, Lena M., Forsblom, Carol, Wadén, Johan, Saraheimo, Markku, Tolonen, Nina, Hietala, Kustaa, Groop, Per-Henrik
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671127/
https://www.ncbi.nlm.nih.gov/pubmed/19196885
http://dx.doi.org/10.2337/dc08-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671127/
https://www.ncbi.nlm.nih.gov/pubmed/19196885
http://dx.doi.org/10.2337/dc08-2022

Ejemplares similares